Pharmaceutical Care Program for dyslipidemic patients at three primary health care centers: Impacts and outcomes

Latin American Journal of Pharmacy

Volumn 28, Issue 3, 2009, Pages 415-420

  Villa, Lorenzo A ^a   Von Chrismar, Ana M ^b   Oyarzún, Carlos ^b   Eujenín, Paloma ^b   Fernández, Maria E ^b   Quezada, Marcela ^b  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

Author keywords

Drug related problem; Dyslipidemia; Pharmaceutical care

Indexed keywords

GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSLIPIDEMIA; EXERCISE; FEMALE; FOOD INTAKE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHYSICAL ACTIVITY; PRIMARY HEALTH CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

EID: 68749089838     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cipolle, R.J., L.M. Strand & P.C. Morley (1998) "Pharmaceutical Care Practice". New York, McGraw-Hill, pp. 2-23.
2. World Health Organization (1994) "The role of the pharmacist in the health care system". Geneva. (unpublished document WHO/ PHARM/94.569).
3. Hepler, C.D. (1987) Am. J. Pharm. Educ. 51: 369-85.
4. van Mil, J.W., L.O. Westerlund, K.E. Hersberger & M.A. Schaefer (2004) Ann. Pharmacother. 38: 859-67.
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report (2002) Circulation 106: 3143-421.
6. Laris, M., A. Arteaga, A. Cuevas & A. Rigotti (2005) Rev. Med. Chile 133: 823-32.
7. Lira, M.T, S. Kunstmann, E. Caballero, E. Guarda, L. Villarroel & J.C. Molina (2006) Rev. Med. Chile. 134: 223-30.
8. Pérez, F., E. Carrasco, J. Santos, M. Calvillan & C. Albala (1999) Rev. Med. Chile 127: 1169-75.
9. Thompson, G. & P. Barter (1999) Curr. Opin. Lipidol. 10: 521-6.
10. Boden, W.E. (2003) Curr. Opin. Cardiol. 18: 278-85.
11. Paulós, C., C. Akesson, C. Celedón & C. Cárcamo (2005) Ann. Pharmacother. 39: 939-43.
12. Blumi, B., J. McKenney & M. Cziraky (2000) J. Am. Pharm. Assoc. 40: 157-65.
13. Goldman, R.E., D.R. Parker, C.B. Eaton, J.M. Borkan, R. Gramling, R.T. Cover & D.K. Ahern (2006) Ann. Fam. Med. 4: 205-12.
14. Hollman, G., A.G. Olsson & A.C. Ek (2006) J. Cardiovasc. Nurs. 21: 103-8.
15. Vargas, M., C. Domecq & C. Maureira (1994) Rev. O.F.I.L. 4: 2-10.
16. Ali, F., M.Y. Laurin, C. Larivière, D. Tremblay & D. Cloutier (2003) Can. J. Clin. Pharmacol. 10: 101-6.
17. Ito, M.K. (2003) Pharmacotherapy 23: 41S-47S.
18. Lee, S.S., P.Y. Cheung & M.S. Chow (2004) J. Clin. Pharmacol. 44: 632-9.
19. Lee, J.K., K.A. Grace & A.J. Taylor (2006) J. Am. Med. Assoc. 296: 2563-71.
20. Porter, A.M. (1969) Br. Med. J. 1: 218-22.
21. Ginsberg, H.N. (2001) Am. J. Cardiol. 87: 1174-80.
22. Denneboom, W., M.G. Dautzenberg, R. Grol & P.A. Smet (2005) J. Clin. Pharm. Ther. 30: 215-23.
23. Vinks, T.H., F.H. de Koning, T.M. de Lange &.C. Egberts (2006) Pharm. World Sci. 28: 33-8.
24. Peterson, G.M., K.D. Fitzmaurice, M. Naunton, J.H. Vial, K. Stewart & H. Krum (2004) J. Clin. Pharm. Ther. 29: 23-30.
25. Volume, CI., KB. Farris, R. Kassam, CE. Cox & A. Cave (2001) J. Am. Pharm. Assoc. 41: 411-20.